Yuhan to introduce 7 original drugs

Published: 2012-06-21 06:57:00

Updated: 2012-06-21 06:57:00

To prepare for government-mandated cuts in drug prices, Yuhan Corp. has recently unveiled its plan to sell seven original brands, including Boehringer Ingelhheim’s Micardis and Gilead’s Truvada, within the year by joining forces with foreign companies to avoid losses.

The company said the pric...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK